ArticleHealth science reports2026
Epidemiology and Burden of Gallbladder and Biliary Diseases and the Socioeconomic Factors in the Region of Middle East and North Africa, 1990-2021: Estimates From the Global Burden of Disease 2021 Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evolution of Gastrointestinal Inflammatory Diseases and Neoplasm Burden in Super-Elderly Populations: Integrated GBD 2023, CHARLS, and CLHLS Analyses of China and G20 Countries.Molecular medicine (Cambridge, Mass.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: As common disorders affecting the digestive system, gallbladder and biliary diseases present a significant health issue. This research aimed to assess the burden of these conditions in the Middle East and North Africa (MENA) region over the period of 1990 to 2021. Furthermore, we investigated the epidemiological characteristics of these diseases in relation to age, sex, and the Socio-demographic Index (SDI). Methods: Drawing from the Global Burden of Disease (GBD) study 2021, we extracted data on the prevalence, incidence, and disability-adjusted life years (DALYs) linked with gallbladder and biliary disease for 21 countries in the MENA region from 1990 to 2021. The results were presented as both absolute numbers and rates per 100,000 people, accompanied by their corresponding 95% uncertainty intervals (UIs). The association between disease burden and SDI was evaluated using smoothing spline models. Results: In 2021, the MENA region documented 4.8 million new cases of gallbladder and biliary diseases, with an age-standardized incidence rate of 808.9 per 100,000 population, which represents a 5.0% reduction since 1990. The prevalence increased to 15.4 million cases, with an age-standardized rate of 2807.5 per 100,000, marking a 7.9% decrease. The overall disease burden, quantified in DALYs, reached 437.1 thousand, with an age-standardized rate of 85.7 per 100,000, signifying a 16.6% decline. Afghanistan estimated the highest DALY rates, while Oman had the lowest. A more pronounced burden was observed in females across all age brackets. An inverse correlation was identified between disease burden and SDI. Conclusion: Gallbladder and biliary diseases continue to be a public health challenge, particularly affecting women, the elderly, and nations with lower SDI levels. It is imperative for each country to develop healthcare systems and preventive measures that are tailored to its specific context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.